Chr. Olesen Group

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Virtual Booth

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

VISIT THE VIRTUAL BOOTH, Contact Details

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

DIGITAL CONTENT

INTERVIEW #SpeakPharma, VLOG #PharmaReel, DATA COMPILATION #PharmaFlow

INTERVIEW #SpeakPharma
VLOG #PharmaReel
DATA COMPILATION #PharmaFlow

ACTIVE PHARMA INGREDIENTS

14 All APIs, 2 USDMF, 8 CEP/COS, 14 Listed APIs

14 All APIs
2 USDMF
8 CEP/COS
14 Listed APIs

INTERMEDIATES

2 ALL Intermediates

2 ALL Intermediates

INSPECTIONS & REGISTRATIONS

6 EDQM

6 EDQM

Xls

Filters

Reset all filters

Filters

FILTER :

filter Product Name Reset all filters

2 All

01 1(R)-5-(2-Aminopropyl)-2-methoxybenzenesulfonamide

02 1Buprenorphine intermediate

filter End Use API Reset all filters

2 All

01 1Buprenorphine

02 1Tamsulosin

filter CAS Number Reset all filters

2 All

01 2Blank

List of Suppliers

Contact Supplier

Reset Filter

Supplier Virtual Booth

Ask Us

Chr. Olesen Synthesis A.S

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Denmark

Virtual Booth

Digital Content

(R)-5-(2-Aminopropyl)-2-methoxybenzenesulfonamide

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

CAS Number

End Use API

Chr. Olesen Synthesis is a Danish manufacturer of APIs and advanced intermediates. Chr. Olesen Synth...

Chr. Olesen Synthesis is a Danish manufacturer of APIs and advanced intermediates. Chr. Olesen Synthesis was established in 2012 after the Chr. Olesen Group acquisition of the multi-purpose synthetic production facility just south of Copenhagen. Chr. Olesen Synthesis is initially active with API’s comprising of molecules like Hydromorphone, Codeine Phosphate, Pramipexole, Terbinafine Risedronate, Tolfenamic Acid, Amphetamine derivatives and advanced intermediates for Buprenorphine and Tamsulosin.